PURPLE INNOVATION INC (PRPL)

US74640Y1064 - Common Stock

1.515  +0.01 (+1%)

After market: 1.515 0 (0%)

Fundamental Rating

1

Taking everything into account, PRPL scores 1 out of 10 in our fundamental rating. PRPL was compared to 68 industry peers in the Household Durables industry. Both the profitability and financial health of PRPL have multiple concerns. PRPL is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year PRPL has reported negative net income.
PRPL had a negative operating cash flow in the past year.
In the past 5 years PRPL reported 4 times negative net income.
In multiple years PRPL reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -30.91%, PRPL is doing worse than 92.54% of the companies in the same industry.
PRPL's Return On Equity of -104.60% is on the low side compared to the rest of the industry. PRPL is outperformed by 91.04% of its industry peers.
Industry RankSector Rank
ROA -30.91%
ROE -104.6%
ROIC N/A
ROA(3y)-17%
ROA(5y)-21.8%
ROE(3y)-51.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PRPL has a Gross Margin of 33.64%. This is in the better half of the industry: PRPL outperforms 71.64% of its industry peers.
In the last couple of years the Gross Margin of PRPL has declined.
PRPL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.56%
GM growth 5Y-3.1%

1

2. Health

2.1 Basic Checks

PRPL does not have a ROIC to compare to the WACC, probably because it is not profitable.
PRPL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PRPL has been increased compared to 5 years ago.
The debt/assets ratio for PRPL is higher compared to a year ago.

2.2 Solvency

PRPL has an Altman-Z score of -0.86. This is a bad value and indicates that PRPL is not financially healthy and even has some risk of bankruptcy.
PRPL has a Altman-Z score of -0.86. This is amonst the worse of the industry: PRPL underperforms 89.55% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that PRPL is not too dependend on debt financing.
The Debt to Equity ratio of PRPL (0.23) is better than 61.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -0.86
ROIC/WACCN/A
WACC10.62%

2.3 Liquidity

PRPL has a Current Ratio of 1.28. This is a normal value and indicates that PRPL is financially healthy and should not expect problems in meeting its short term obligations.
PRPL has a worse Current ratio (1.28) than 88.06% of its industry peers.
A Quick Ratio of 0.68 indicates that PRPL may have some problems paying its short term obligations.
The Quick ratio of PRPL (0.68) is worse than 74.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.68

3

3. Growth

3.1 Past

PRPL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -54.76%.
The Revenue for PRPL has decreased by -11.07% in the past year. This is quite bad
PRPL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.30% yearly.
EPS 1Y (TTM)-54.76%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-50%
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-7.66%
Revenue growth 5Y12.3%
Revenue growth Q2Q0.58%

3.2 Future

The Earnings Per Share is expected to grow by 17.74% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.52% on average over the next years.
EPS Next Y41.74%
EPS Next 2Y29.33%
EPS Next 3Y21.91%
EPS Next 5Y17.74%
Revenue Next Year6.64%
Revenue Next 2Y7.43%
Revenue Next 3Y7.82%
Revenue Next 5Y7.52%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

PRPL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PRPL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PRPL's earnings are expected to grow with 21.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.33%
EPS Next 3Y21.91%

0

5. Dividend

5.1 Amount

PRPL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PURPLE INNOVATION INC

NASDAQ:PRPL (4/26/2024, 7:11:15 PM)

After market: 1.515 0 (0%)

1.515

+0.01 (+1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap162.42M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.91%
ROE -104.6%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 33.64%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.28
Quick Ratio 0.68
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-54.76%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y41.74%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-7.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y